课题基金 / 基金详情

Use of sodium glucose co-transporter-2 inhibitors and the risk of dementia

Use of sodium glucose co-transporter-2 inhibitors and the risk of dementia
钠葡萄糖协同转运蛋白 2 抑制剂的使用与痴呆风险
批准号：
451723
负责人：
Yu Oriana Hoi Yun
金额：
$8.74万
依托单位：
Lady Davis Institute for Medical Research (Mtl)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-09-01 至 2023-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=451723&lang=en
关键词：
Diabetes Pharmacoepidemiology Sodium Glucose Cotransporter-2 Inhibitors

项目摘要

项目成果

Yu Oriana Hoi Yun的其他基金

相似基金

相关文献

中文摘要
翻译
2型糖尿病患者有更高的风险发展认知能力下降，导致痴呆症。患有痴呆症的人有更高的并发症和死亡风险，生活质量显著下降。mec所
英文摘要
People with type 2 diabetes have a higher risk of developing a decline in cognitive ability, which leads to dementia. People who suffer from dementia have higher risks of complications and death and a significant decrease in their quality of life. The mec
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The association between denosumab and the risk of atypical femoral fractures in osteoporosis management
Thyroid hormone replacement therapy and the risk of adverse cardiovascular events among individuals with mild subclinical hypothyroidism.
海外基金